Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton pump inhibitor prophylaxis to prevent anastomotic stricture after oesophageal atresia repair
ISRCTN96912679Phase 3Recruiting
- Sponsor
- University of Oxford
- Start
- Nov 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of esomeprazole and omeprazole in esophageal atresia (EA) and tracheoesophageal fistula (TEF), sponsored by University of Oxford. Primary endpoint: Primary: severity of anastomotic stricture up to 1 year. Started Nov 2025; status: recruiting.
02
Drugs
esomeprazoleomeprazole
03
Conditions
esophageal atresia (EA)tracheoesophageal fistula (TEF)
Beyond the preview
Go deeper on ISRCTN96912679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96912679.